Certara (NASDAQ:CERT) Earns Buy Rating from Analysts at TD Cowen

TD Cowen began coverage on shares of Certara (NASDAQ:CERT) in a report issued on Thursday morning, MarketBeat Ratings reports. The firm issued a buy rating and a $16.00 price objective on the stock.

Several other analysts have also recently commented on the company. Robert W. Baird lowered their target price on Certara from $18.00 to $13.00 and set a “neutral” rating on the stock in a research report on Tuesday, November 5th. Barclays lowered their target price on Certara from $14.00 to $12.00 and set an “equal weight” rating on the stock in a research report on Thursday, November 7th. Four research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $15.83.

Certara Stock Down 3.4 %

Shares of Certara stock opened at $11.98 on Thursday. The company has a current ratio of 2.86, a quick ratio of 2.86 and a debt-to-equity ratio of 0.28. The business’s 50 day simple moving average is $12.45 and its 200-day simple moving average is $11.63. The stock has a market capitalization of $1.93 billion, a price-to-earnings ratio of -59.90, a PEG ratio of 9.29 and a beta of 1.57. Certara has a twelve month low of $9.41 and a twelve month high of $19.87.

Hedge Funds Weigh In On Certara

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its stake in Certara by 0.3% during the 4th quarter. Vanguard Group Inc. now owns 12,437,089 shares of the company’s stock valued at $132,455,000 after purchasing an additional 38,068 shares in the last quarter. Wasatch Advisors LP boosted its stake in Certara by 22.4% during the 3rd quarter. Wasatch Advisors LP now owns 9,015,941 shares of the company’s stock valued at $105,577,000 after purchasing an additional 1,651,076 shares in the last quarter. ArrowMark Colorado Holdings LLC boosted its stake in Certara by 164.2% during the 4th quarter. ArrowMark Colorado Holdings LLC now owns 6,213,278 shares of the company’s stock valued at $66,171,000 after purchasing an additional 3,861,674 shares in the last quarter. Geneva Capital Management LLC boosted its stake in Certara by 0.7% during the 3rd quarter. Geneva Capital Management LLC now owns 5,510,209 shares of the company’s stock valued at $64,525,000 after purchasing an additional 37,392 shares in the last quarter. Finally, Teacher Retirement System of Texas boosted its stake in Certara by 13.9% during the 4th quarter. Teacher Retirement System of Texas now owns 4,557,951 shares of the company’s stock valued at $48,542,000 after purchasing an additional 557,348 shares in the last quarter. 73.96% of the stock is owned by institutional investors.

About Certara

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.